6th ESH Translational Research Conference: Lymphoid Malignancies - Targeting the TLR pathway with BTK inhibitors in Waldenström’s Macroglobulinemia

 VIDEO   10:40   11/2021

ESH 2021 - BeiGene Targeting the TLR pathway with BTK inhibitors in Waldenström’s Macroglobulinemia (WM)

Saturday, 16th October 2021, 14:30 – 15:30 (CEST)

 

Steven Treon
Director
Bing Center for Waldenström’s
Macroglobulinemia, Senior Physician,
Dana-Farber Cancer Institute; Professor of
Medicine, Harvard Medical School
Boston, USA

Rating

Rate this resource